Hisamitsu Pharmaceutical : Notice regarding Providing Relief Supplies in Response to the Torrential Rains from July 7, 2023
July 26, 2023
Share
This material is an English translation of the press release announced on Jul. 27, 2023 in Japanese, and the Japanese release is given priority about the content and the interpretation.
Jul. 27, 2023
Notice regarding Providing Relief Supplies in
Response to the Torrential Rains from July 7, 2023
We would like to express our heartfelt sympathy to the victims of the torrential rains from July 7, 2023.
Hisamitsu Pharmaceutical Co., Inc. (Head Office: Tosu City, Saga Prefecture; President and CEO: NAKATOMI, Kazuhide; hereinafter referred to as "Hisamitsu Pharmaceutical") has provided the following products as relief supplies free of charge based on the "agreement on support and cooperation in the event of a disaster" signed with the Japanese Red Cross Society (Headquarters: Minato-ku, Tokyo; President: Yoshiharu Otsuka) on January 31, 2020.
Relief supplies
• Refresh Body Sheet 28,800 pieces
Hisamitsu Pharmaceutical will continue to provide support to the people affected by disasters and those involved in relief activities. We sincerely hope for the earliest possible recovery of the affected areas.
The agreement on support and cooperation in the event of a disaster is intended to ensure the smooth implementation of disaster emergency response measures and disaster recovery measures in the event of a disaster, such as an earthquake or typhoon, by providing the Japanese Red Cross Society free of charge with supplies that Hisamitsu Pharmaceutical can provide in response to the needs of disaster victims, Japanese Red Cross Society staff members involved in disaster response, Red Cross volunteers, etc.
Attachments
Original Link
Original Document
Permalink
Disclaimer
Hisamitsu Pharmaceutical Co. Ltd. published this content on 27 July 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 09 August 2023 02:56:40 UTC.
Hisamitsu Pharmaceutical Co Inc is a Japan-based company mainly engaged in the pharmaceutical business. The Company is engaged in the manufacture, sale and supply of pharmaceuticals and related products, and the operation of over-the-counter drug (OTC) business. It is also engaged in the manufacture and sale of drugs in the United States, Brazil, Vietnam, and Indonesia, the development work in Europe, the drug marketing and sales in China and Hong Kong. It is also engaged in the urban cable television broadcasting business, Internet connection service business, non-life insurance agency business, advertising agency business and the purchase, manufacture and sale of packing materials.
HISAMITSU PHARMACEUTICAL CO., INC. 
